Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Drugs & Aging|October 2, 2010
Changes in under-treatment after comprehensive geriatric assessment: an observational studyLinda R Tulner, Jos P C M van Campen, Suzanne V Frankfort, et al.
The American Journal of Geriatric Pharmacotherapy|May 19, 2009
Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactionsLinda R Tulner, Ingeborg M J A Kuper, Suzanne V Frankfort, et al.
Pharmacoepidemiology and Drug Safety|November 17, 2006
Identification of responders and reactive domains to rivastigmine in Alzheimer's diseaseS V Frankfort, B A Appels, A de Boer, et al.
The American Journal of Geriatric Pharmacotherapy|September 22, 2009
Treatment of hypertension in an elderly outpatient population in the NetherlandsLinda R Tulner, Ingeborg M J A Kuper, Jos P C M van Campen, et al.
Current Drug Safety|March 10, 2010
Contraindications for anticoagulation in older patients with atrial fibrillation; a narrative reviewLinda R Tulner, Ingeborg M J A Kuper, Jos P C M van Campen, et al.
Journal of the American Medical Directors Association|July 15, 2024
Potentially Inappropriate Medication in Older Persons With Dementia: Does a Migration Background Matter?Bianca T Strooij, Marieke T Blom, Hein P J van Hout, et al.
Drugs & Aging|December 25, 2009
Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive studyLinda R Tulner, Jos P C M Van Campen, Ingeborg M J A Kuper, et al.
BMC Geriatrics|August 28, 2015
Dutch family physicians' awareness of cognitive impairment among the elderlyPim van den Dungen, Eric P Moll van Charante, Peter M van de Ven, et al.
Age and Ageing|June 26, 2014
Specifying ICD9, ICPC and ATC codes for the STOPP/START criteria: a multidisciplinary consensus panelDominique A de Groot, Marloes de Vries, Karlijn J Joling, et al.
Pageof 5